LCN2 and Cognitive impairment: At the molecular level, MASLD altered the expression of key hippocampal genes-including <i>TCF7L2</i>, <i>LCN2</i>, and <i>AQP1</i>-impacting immune response, lipid metabolism, and apoptotic pathways, which collectively contributed to cognitive deficits.